Steven Bellon
Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
Current
2022-01-10–present
-
Foghorn Therapeutics Inc. (FHTX)
Proxy statement
Current
Company network
Recorded roles and earnings-call appearances connecting this person to public companies.
Executive compensation
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2025 | Foghorn Therapeutics Inc. (FHTX) | Chief Science Officer | $505,000 | $1,199,455 |
| 2024 | Foghorn Therapeutics Inc. (FHTX) | Chief Science Officer | $485,000 | $902,212 |
| 2023 | Foghorn Therapeutics Inc. (FHTX) | Ph.D.. Chief Scientific Officer | $445,000 | $1,187,494 |
| 2022 | Foghorn Therapeutics Inc. (FHTX) | Ph.D.. Chief Scientific Officer | $435,000 | $2,145,667 |
Recent activity
No earnings-call appearances or filed executive changes recorded yet.